Measurement of plasma uracil using gas chromatography-mass spectrometry in normal individuals and in patients receiving inhibitors of dihydropyrimidine dehydrogenase

Daoqin Bi, Lawrence W. Anderson, Jeremy Shapiro, Alla Shapiro, Jean L. Grem, Chris H. Takimoto

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

A sensitive gas chromatographic-mass spectrometric method is described for reliably measuring endogenous uracil in 100 μl of human plasma. Validation of this assay over a wide concentration range, 0.025 ♂m to 250 ♂m (0.0028 μg/ml to 28 μg/ml), allowed for the determination of plasma uracil in patients treated with agents such as eniluracil, an inhibitor of the pyrimidine catabolic enzyme, dihydropyrimidine dehydrogenase. Calibration standards were prepared in human plasma using the stable isotope, [15N2]uracil, to avoid interference from endogenous uracil and 10 ♂m 5- chlorouracil was added as the internal standard.

Original languageEnglish (US)
Pages (from-to)249-258
Number of pages10
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume738
Issue number2
DOIs
StatePublished - Feb 11 2000

Fingerprint

Dihydrouracil Dehydrogenase (NADP)
Uracil
Gas chromatography
Mass spectrometry
Plasma (human)
Plasmas
Isotopes
Assays
Gases
Calibration
Enzymes

Keywords

  • Dihydropyrimidine dehydrogenase
  • Eniluracil
  • Uracil

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Measurement of plasma uracil using gas chromatography-mass spectrometry in normal individuals and in patients receiving inhibitors of dihydropyrimidine dehydrogenase. / Bi, Daoqin; Anderson, Lawrence W.; Shapiro, Jeremy; Shapiro, Alla; Grem, Jean L.; Takimoto, Chris H.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 738, No. 2, 11.02.2000, p. 249-258.

Research output: Contribution to journalArticle

@article{980eabb4e44c465eb130c98f1df68624,
title = "Measurement of plasma uracil using gas chromatography-mass spectrometry in normal individuals and in patients receiving inhibitors of dihydropyrimidine dehydrogenase",
abstract = "A sensitive gas chromatographic-mass spectrometric method is described for reliably measuring endogenous uracil in 100 μl of human plasma. Validation of this assay over a wide concentration range, 0.025 ♂m to 250 ♂m (0.0028 μg/ml to 28 μg/ml), allowed for the determination of plasma uracil in patients treated with agents such as eniluracil, an inhibitor of the pyrimidine catabolic enzyme, dihydropyrimidine dehydrogenase. Calibration standards were prepared in human plasma using the stable isotope, [15N2]uracil, to avoid interference from endogenous uracil and 10 ♂m 5- chlorouracil was added as the internal standard.",
keywords = "Dihydropyrimidine dehydrogenase, Eniluracil, Uracil",
author = "Daoqin Bi and Anderson, {Lawrence W.} and Jeremy Shapiro and Alla Shapiro and Grem, {Jean L.} and Takimoto, {Chris H.}",
year = "2000",
month = "2",
day = "11",
doi = "10.1016/S0378-4347(99)00528-9",
language = "English (US)",
volume = "738",
pages = "249--258",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "1387-2273",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Measurement of plasma uracil using gas chromatography-mass spectrometry in normal individuals and in patients receiving inhibitors of dihydropyrimidine dehydrogenase

AU - Bi, Daoqin

AU - Anderson, Lawrence W.

AU - Shapiro, Jeremy

AU - Shapiro, Alla

AU - Grem, Jean L.

AU - Takimoto, Chris H.

PY - 2000/2/11

Y1 - 2000/2/11

N2 - A sensitive gas chromatographic-mass spectrometric method is described for reliably measuring endogenous uracil in 100 μl of human plasma. Validation of this assay over a wide concentration range, 0.025 ♂m to 250 ♂m (0.0028 μg/ml to 28 μg/ml), allowed for the determination of plasma uracil in patients treated with agents such as eniluracil, an inhibitor of the pyrimidine catabolic enzyme, dihydropyrimidine dehydrogenase. Calibration standards were prepared in human plasma using the stable isotope, [15N2]uracil, to avoid interference from endogenous uracil and 10 ♂m 5- chlorouracil was added as the internal standard.

AB - A sensitive gas chromatographic-mass spectrometric method is described for reliably measuring endogenous uracil in 100 μl of human plasma. Validation of this assay over a wide concentration range, 0.025 ♂m to 250 ♂m (0.0028 μg/ml to 28 μg/ml), allowed for the determination of plasma uracil in patients treated with agents such as eniluracil, an inhibitor of the pyrimidine catabolic enzyme, dihydropyrimidine dehydrogenase. Calibration standards were prepared in human plasma using the stable isotope, [15N2]uracil, to avoid interference from endogenous uracil and 10 ♂m 5- chlorouracil was added as the internal standard.

KW - Dihydropyrimidine dehydrogenase

KW - Eniluracil

KW - Uracil

UR - http://www.scopus.com/inward/record.url?scp=0033975442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033975442&partnerID=8YFLogxK

U2 - 10.1016/S0378-4347(99)00528-9

DO - 10.1016/S0378-4347(99)00528-9

M3 - Article

C2 - 10718643

AN - SCOPUS:0033975442

VL - 738

SP - 249

EP - 258

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 1387-2273

IS - 2

ER -